Quick Takeaways
- RLMD - RELMADA THERAPEUTICS, INC. has 9 insiders with reported activity on this page.
- Net insider value flow over the last year: +$2,997,466.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 9 Insiders of RELMADA THERAPEUTICS, INC.
- Symbol
- RLMD on Nasdaq
- Location
- Coral Gables, FL
What Changed
- Buy value: $2,997,466; sell value: $0.
- Net share flow: +2,282,602.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$2,997,466.
Buys
$2,997,466
Shares: 2,282,602
Insiders: 4
Sells
$0
Shares: 0
Insiders: 0
Net
+$2,997,466
Shares: +2,282,602
Insiders: 4
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 1,037,665 | 0 | $2,358,060 | $0 | +$2,358,060 |
| 6-9 | 265,976 | 0 | $178,095 | $0 | +$178,095 |
| 9-12 | 978,961 | 0 | $461,311 | $0 | +$461,311 |
RELMADA THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Sergio Traversa | Chief Executive Officer, Director | $5,356,000 | +$1,065,608 | +25% | Filing P/S | 12 Dec 2025 |
| Maged Shenouda | Chief Financial Officer | $3,296,000 | +$1,245,268 | +61% | Filing P/S | 12 Dec 2025 |
| Paul Edward Kelly | COO, Director | $1,105,049 | +$284,060 | +35% | Filing P/S | 12 Dec 2025 |
| Chuck Ence | CA and CO | $888,648 | +$402,530 | +83% | Filing P/S | 12 Dec 2025 |
| Cedric O'Gorman | Chief Medical Officer | $32,185 | Filing P/S | 23 May 2023 | ||
| Fabiana Fedeli | Director | Mixed | 12 Dec 2025 | |||
| Charles J. Casamento | Director | Mixed | 12 Dec 2025 | |||
| John Glasspool | Director | Mixed | 12 Dec 2025 | |||
| Eric Thomas Schmidt | Director | Mixed | 25 May 2023 |
Top shareholders of RELMADA THERAPEUTICS, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
10%
|
7,439,415
|
$35,932,374 | $0 | 30 Jan 2026 | |
| Squadron Capital Management LLC |
13F
13D/G
|
Company · Squadron Master Fund LP |
9.9%
from 13D/G
|
6,700,000
|
$32,361,000 | — | 31 Dec 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
5.7%
|
4,270,000
|
$20,624,100 | — | 31 Dec 2025 | |
| Spruce Street Capital LP |
13F
13D/G
|
Company |
5.6%
from 13D/G
|
4,086,181
|
$19,736,254 | — | 31 Dec 2025 | |
| Adage Capital Management, L.P. |
13D/G
|
— |
5.8%
|
4,270,000
|
$18,062,100 | $0 | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
4.3%
|
3,189,662
|
$15,406,068 | — | 31 Dec 2025 | |
| Ikarian Capital, LLC |
13F
13D/G
|
Company |
4.8%
from 13D/G
|
3,068,359
|
$14,820,175 | — | 31 Dec 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
3.5%
|
2,610,600
|
$12,609,198 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
2.6%
|
1,920,099
|
$9,274,078 | — | 31 Dec 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.5%
|
1,880,006
|
$9,080,429 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.2%
|
1,673,017
|
$8,080,672 | — | 31 Dec 2025 | |
| BRAIDWELL LP |
13F
|
Company |
2.1%
|
1,582,257
|
$7,642,301 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.7%
|
1,267,503
|
$6,122,039 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
1,203,307
|
$5,811,973 | — | 31 Dec 2025 | |
| Sergio Traversa |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
3,298,000
mixed-class rows
|
$5,356,000 | +$1,065,608 | 12 Dec 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
1.3%
|
935,000
|
$4,516,050 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
854,932
|
$4,131,406 | — | 31 Dec 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
835,300
|
$4,034,499 | — | 31 Dec 2025 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.96%
|
719,582
|
$3,443,379 | — | 31 Dec 2025 | |
| Maged Shenouda |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
2,228,000
mixed-class rows
|
$3,296,000 | +$1,245,268 | 12 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.77%
|
572,835
|
$2,766,793 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.73%
|
547,854
|
$2,646,135 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.71%
|
526,718
|
$2,541,000 | — | 31 Dec 2025 | |
| DIADEMA PARTNERS LP |
13F
|
Company |
0.52%
|
389,395
|
$1,880,778 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.52%
|
385,942
|
$1,864,100 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.43%
|
320,820
|
$1,549,561 | — | 31 Dec 2025 | |
| AdvisorShares Investments LLC |
13F
|
Company |
0.43%
|
319,510
|
$1,543,233 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.36%
|
271,109
|
$1,309,456 | — | 31 Dec 2025 | |
| PARSONS CAPITAL MANAGEMENT INC/RI |
13F
|
Company |
0.35%
|
263,000
|
$1,270,290 | — | 31 Dec 2025 | |
| Persistent Asset Partners Ltd |
13F
|
Company |
0.31%
|
231,123
|
$1,116,324 | — | 31 Dec 2025 | |
| Paul Edward Kelly |
3/4/5
|
COO, Director |
—
mixed-class rows
|
1,730,295
mixed-class rows
|
$1,105,049 | +$284,060 | 12 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.3%
|
224,846
|
$1,086,006 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.25%
|
187,377
|
$905,031 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.25%
|
185,000
|
$893,550 | — | 31 Dec 2025 | |
| Chuck Ence |
3/4/5
|
CA and CO |
—
mixed-class rows
|
1,631,931
mixed-class rows
|
$888,648 | +$402,530 | 12 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.22%
|
165,453
|
$799,138 | — | 31 Dec 2025 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.22%
|
162,552
|
$785,126 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.22%
|
162,200
|
$783,426 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.21%
|
155,529
|
$751,205 | — | 31 Dec 2025 | |
| Seven Fleet Capital Management LP |
13F
|
Company |
0.21%
|
154,109
|
$744,346 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.19%
|
145,000
|
$700,350 | — | 31 Dec 2025 | |
| RBF Capital, LLC |
13F
|
Company |
0.19%
|
140,000
|
$676,200 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.19%
|
138,233
|
$667,665 | — | 31 Dec 2025 | |
| MGO ONE SEVEN LLC |
13F
|
Company |
0.13%
|
100,000
|
$483,000 | — | 31 Dec 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.13%
|
98,965
|
$478,001 | — | 31 Dec 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.09%
|
68,883
|
$332,705 | — | 31 Dec 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.09%
|
65,900
|
$318,297 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
62,357
|
$301,185 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
60,000
|
$289,800 | — | 31 Dec 2025 | |
| LMR Partners LLP |
13F
|
Company |
0.07%
|
55,600
|
$268,548 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for RELMADA THERAPEUTICS, INC.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Sergio Traversa | RLMD | Common Stock | Purchase | 2.16% | $113,300 | $4.12 | 27,500 | 1,300,000 | 15 Dec 2025 | Direct |
| Maged Shenouda | RLMD | Common Stock | Purchase | 1.48% | $48,060 | $4.12 | 11,665 | 800,000 | 15 Dec 2025 | Direct |
| Sergio Traversa | RLMD | Stock Appreciation Rights | Award | 1,198,000 | 1,198,000 | 12 Dec 2025 | Direct | |||
| Maged Shenouda | RLMD | Stock Appreciation Rights | Award | 828,000 | 828,000 | 12 Dec 2025 | Direct | |||
| Chuck Ence | RLMD | Stock Appreciation Rights | Award | 828,000 | 828,000 | 12 Dec 2025 | Direct | |||
| Fabiana Fedeli | RLMD | Stock Appreciation Rights | Award | 164,000 | 164,000 | 12 Dec 2025 | Direct | |||
| John Glasspool | RLMD | Stock Appreciation Rights | Award | 164,000 | 164,000 | 12 Dec 2025 | Direct | |||
| Paul Edward Kelly | RLMD | Stock Appreciation Rights | Award | 828,000 | 828,000 | 12 Dec 2025 | Direct | |||
| Charles J. Casamento | RLMD | Stock Appreciation Rights | Award | 164,000 | 164,000 | 12 Dec 2025 | Direct | |||
| Chuck Ence | RLMD | Common Stock | Purchase | 50.8% | $299,200 | $2.20 | 136,000 | 403,931 | 05 Nov 2025 | Direct |
| Sergio Traversa | RLMD | Common Stock | Purchase | 27.2% | $599,500 | $2.20 | 272,500 | 1,272,500 | 05 Nov 2025 | Direct |
| Maged Shenouda | RLMD | Common Stock | Purchase | 173.4% | $1,100,000 | $2.20 | 500,000 | 788,335 | 05 Nov 2025 | Direct |
| Paul Edward Kelly | RLMD | Common Stock | Purchase | 21.8% | $198,000 | $2.20 | 90,000 | 502,295 | 05 Nov 2025 | Direct |
| Sergio Traversa | RLMD | Common Stock | Purchase | 5.93% | $41,422 | $0.7400 | 55,976 | 1,000,000 | 28 Aug 2025 | Direct |
| Sergio Traversa | RLMD | Common Stock | Purchase | 15.9% | $86,735 | $0.6700 | 129,455 | 944,024 | 27 Aug 2025 | Direct |
| Sergio Traversa | RLMD | Common Stock | Purchase | 11% | $49,938 | $0.6200 | 80,545 | 814,569 | 26 Aug 2025 | Direct |
| Chuck Ence | RLMD | Stock Option (right to buy) | Award | 400,000 | 400,000 | 26 Jun 2025 | Direct | |||
| Maged Shenouda | RLMD | Stock Option (right to buy) | Award | 600,000 | 600,000 | 26 Jun 2025 | Direct | |||
| Sergio Traversa | RLMD | Stock Option (right to buy) | Award | 800,000 | 800,000 | 26 Jun 2025 | Direct | |||
| Charles J. Casamento | RLMD | Stock Option (right to buy) | Award | 100,000 | 100,000 | 26 Jun 2025 | Direct | |||
| John Glasspool | RLMD | Stock Option (right to buy) | Award | 100,000 | 100,000 | 26 Jun 2025 | Direct | |||
| Fabiana Fedeli | RLMD | Stock Option (right to buy) | Award | 100,000 | 100,000 | 26 Jun 2025 | Direct | |||
| Paul Edward Kelly | RLMD | Stock Option (right to buy) | Award | 400,000 | 400,000 | 26 Jun 2025 | Direct | |||
| Maged Shenouda | RLMD | Common Stock | Purchase | 26.3% | $31,422 | $0.5237 | 60,000 | 288,335 | 20 May 2025 | Direct |
| Sergio Traversa | RLMD | Common Stock | Purchase | 25.2% | $82,246 | $0.5569 | 147,686 | 734,024 | 20 May 2025 | Direct |
| Maged Shenouda | RLMD | Common Stock | Purchase | 65.1% | $43,686 | $0.4854 | 90,000 | 228,335 | 19 May 2025 | Direct |
| Sergio Traversa | RLMD | Common Stock | Purchase | 5.39% | $14,994 | $0.4998 | 30,000 | 586,338 | 19 May 2025 | Direct |
| Paul Edward Kelly | RLMD | Common Stock | Purchase | 94.2% | $86,060 | $0.4303 | 200,000 | 412,295 | 16 May 2025 | Direct |
| Maged Shenouda | RLMD | Common Stock | Purchase | 56.6% | $22,100 | $0.4420 | 50,000 | 138,335 | 16 May 2025 | Direct |
| Chuck Ence | RLMD | Common Stock | Purchase | 587.5% | $103,330 | $0.4513 | 228,961 | 267,931 | 16 May 2025 | Direct |
| Sergio Traversa | RLMD | Common Stock | Purchase | 44.9% | $77,472 | $0.4496 | 172,314 | 556,338 | 16 May 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.